Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 28, 2007; 13(12): 1824-1827
Published online Mar 28, 2007. doi: 10.3748/wjg.v13.i12.1824
Published online Mar 28, 2007. doi: 10.3748/wjg.v13.i12.1824
Case No. | Age(yr) | IAHSS | New onset AIH | BMI(m/kg2) | HE | SIRS | Bilirubin(mg/dL) | ALT(IU/L) | ALP(UI/L) | INR | Globulin(g/dL) | Creatinine(mg/dL) | ANA | Corticosteroids |
1.31 | 65 | 17 | Yes | 31.1 | 2 | Yes | 21.9 | 309 | 274 | 1.60 | 4.1 | 1.1 | 1:40 | Yes |
1.22 | 17 | 17 | Yes | 22.0 | 3 | Yes | 15.3 | 358 | 136 | 1.50 | 2.5 | 0.9 | 1:40 | Yes |
23 | 66 | 17 | No | 20.0 | 2 | Yes | 8.4 | 31 | 207 | 1.50 | 4.4 | 0.9 | 1:80 | Yes |
1.24 | 28 | 17 | Yes | 30.3 | 2 | Yes | 22.9 | 128 | 262 | 1.90 | 5.7 | 1.1 | 1:80 | Yes |
1.25 | 52 | 14 | Yes | 27.5 | 2 | No | 21.2 | 217 | 186 | 1.90 | 4.5 | 0.6 | 1:40 | No |
16 | 17 | 20 | Yes | 22.5 | 2 | No | 7.6 | 414 | 271 | 1.70 | 7.7 | 0.8 | 1:80 | Yes |
7 | 31 | 18 | No | 19.9 | 4 | Yes | 22.0 | 541 | 138 | 3.60 | 2.9 | 6.6 | 1:80 | Yes |
8 | 25 | 14 | No | 35.0 | 3 | Yes | 26.8 | 23 | 309 | 1.90 | 3.1 | 2.7 | 1:40 | No |
1.39 | 67 | 13 | Yes | 26.9 | 2 | No | 13.8 | 683 | 135 | 8.12 | 2.4 | 2.3 | 1:80 | No |
10 | 18 | 12 | Yes | 27.0 | 3 | Yes | 22.6 | 126 | 120 | 2.20 | 2.7 | 1.1 | 1:40 | No |
11 | 33 | 13 | Yes | 23.3 | 3 | Yes | 20.1 | 173 | 199 | 3.60 | 4.3 | 1.4 | 1:80 | No |
Variables | In-hospital survival (n = 6) median (range) | In-hospital non-survival (n = 5) median (range) | P |
Age (yr) | 52 (17-67) | 29.5 (18–66) | 0.43 |
HE grade (III or IV), n (%) | 1 (16) | 4 (80) | 0.10 |
Body mass index (m/kg2) | 26.9 (22–31.1) | 25.1 (20–35) | 0.39 |
APACHE score | 8 (6–13) | 20 (11–23) | 0.08 |
Total bilirubin (mg/dL) | 15.3 (7.6–21.9) | 22.3 (8.4–26.8) | 0.35 |
Alanine aminotransferase (IU/L) | 358 (217–683) | 127 (23–541) | 0.35 |
INR | 1.7 (1.5–8.12) | 2.05 (1.5–3.6) | 0.35 |
Creatinine (mg/dL) | 0.9 (0.6–2.3) | 1.25 (0.9–6.6) | 0.20 |
Serum sodium (mEq/L) | 134 (131–138) | 134 (125–149) | 0.35 |
SIRS (yes), n (%) | 0 | 1 (20) | 0.45 |
Sepsis (yes), n (%) | 1 (16) | 2 (33.2) | 0.42 |
Severe sepsis (yes), n (%) | 1 (16) | 3 (60) | 0.19 |
Septic shock (yes), n (%) | 0 | 0 | NS |
Multiple organic failure (yes), n (%) | 0 | 5 (100) | 0.02 |
Corticosteroids (yes), n (%) | 5 (83) | 1 (20) | 0.06 |
- Citation: Chavez-Tapia NC, Martinez-Salgado J, Granados J, Uribe M, Tellez-Avila FI. Clinical heterogeneity in autoimmune acute liver failure. World J Gastroenterol 2007; 13(12): 1824-1827
- URL: https://www.wjgnet.com/1007-9327/full/v13/i12/1824.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i12.1824